Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection

MT Newswires Live

2025/06/06

Jointown Pharmaceutical Group (SHA:600998), through its unit Beijing Jingfeng Pharmaceutical Group, obtained a drug registration certificate from China's National Medical Products Administration for betamethasone sodium phosphate injection, according to a Shanghai bourse disclosure on Thursday.

The drug is used to treat allergic and autoimmune inflammatory diseases, such as rheumatoid arthritis, severe bronchial asthma, and severe dermatitis.

The certificate is valid until May 26, 2030, the pharmaceutical company said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2541083988"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541083988\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541083988?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-06 16:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541083988","market":"us","top_or_hot":-1,"title":"Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection","media":"MT Newswires Live","content":"<html><body><p> Jointown Pharmaceutical Group (SHA:600998), through its unit Beijing Jingfeng Pharmaceutical Group, obtained a drug registration certificate from China's National Medical Products Administration for betamethasone sodium phosphate injection, according to a Shanghai bourse disclosure on Thursday.</p><p>The drug is used to treat allergic and autoimmune inflammatory diseases, such as rheumatoid arthritis, severe bronchial asthma, and severe dermatitis.</p><p>The certificate is valid until May 26, 2030, the pharmaceutical company said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-06-06 16:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Jointown Pharmaceutical Group (SHA:600998), through its unit Beijing Jingfeng Pharmaceutical Group, obtained a drug registration certificate from China's National Medical Products Administration for betamethasone sodium phosphate injection, according to a Shanghai bourse disclosure on Thursday.</p><p>The drug is used to treat allergic and autoimmune inflammatory diseases, such as rheumatoid arthritis, severe bronchial asthma, and severe dermatitis.</p><p>The certificate is valid until May 26, 2030, the pharmaceutical company said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2541083988","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541083988","pubTimestamp":1749196911,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Jointown Pharmaceutical Group , through its unit Beijing Jingfeng Pharmaceutical Group, obtained a drug registration certificate from China's National Medical Products Administration for betamethasone sodium phosphate injection, according to a Shanghai bourse disclosure on Thursday.The drug is used to treat allergic and autoimmune inflammatory diseases, such as rheumatoid arthritis, severe bronchial asthma, and severe dermatitis.The certificate is valid until May 26, 2030, the pharmaceutical company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600998":"九州通","BK0183":"MSCI概念","BK0201":"可转债","5WV.SI":"亚化集团","BK0188":"融资融券","BK0028":"国家队","BK0012":"证金概念","BK0187":"一线龙头","BK0196":"行业龙头","BK0077":"质押式回购","BK0250":"批发","BK0039":"民营银行","BK0097":"医药电商","BK0146":"智慧医疗"},"translate_title":"九州通医药倍他米松磷酸钠注射液获药品注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600998":0.9,"5WV.SI":1},"content_text":"Jointown Pharmaceutical Group (SHA:600998), through its unit Beijing Jingfeng Pharmaceutical Group, obtained a drug registration certificate from China's National Medical Products Administration for betamethasone sodium phosphate injection, according to a Shanghai bourse disclosure on Thursday.The drug is used to treat allergic and autoimmune inflammatory diseases, such as rheumatoid arthritis, severe bronchial asthma, and severe dermatitis.The certificate is valid until May 26, 2030, the pharmaceutical company said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}